cs.AINov 13, 2026

Causally Constrained and Uncertainty-Aware Cardiopulmonary Risk Prediction

Authors: Yuxiang Lai, Jiashuo Zhang, Liang Zhao, Xiaofeng Yang

Organizations: Department of Computer Science, Emory University, Atlanta, GA, USA. · Department of Computer Science, Johns Hopkins University, Baltimore, MD, USA. · Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL, USA.

Abstract

Routine chest computed tomography (CT) captures pulmonary, cardiac, and vascular phenotypes that jointly stratify lung cancer and cardiovascular disease, the two leading causes of death in lung-screening populations. Yet clinical risk calculators evaluate each disease in isolation and omit CT findings, whereas unconstrained machine learning overfits small hospital cohorts, learns treatment- and illness-confounded risk directions, and conceals uncertainty when patient records are incomplete. Here we present the Causal Envelope Agent (CE-Agent), a two-stage framework that compiles peer-reviewed epidemiological evidence into explicit constraints on risk-factor weights before any outcome is seen, while estimating local baseline risk and newly added CT phenotypes from cohort data. At deployment, closed-form uncertainty propagation accounts for missing clinical or CT inputs within milliseconds per patient, running over two orders of magnitude faster than Monte Carlo sampling and returning calibrated risk intervals that direct chart review and selective imaging to borderline patients. Across 53,452 lung-screening participants from 33 US hospitals and 6,814 multi-ethnic adults, CE-Agent outperforms cardiovascular calculators in lung screening, exceeds the Pooled Cohort Equations on hard atherosclerotic events while correcting their 1.7-fold risk overestimation, and generalizes from a single hospital or CT scanner to external sites while lowering required sample sizes up to fivefold. Applied unchanged to lung cancer, CE-Agent matches established screening models with accurate calibration even when restricted to risk-factor directions alone, and pairing both predictions improves joint cardiopulmonary triage from a single screening visit.

Figures & tables

Appendix figures & tables26 assets

Supplementary material from the paper’s appendix.

Appendix

Explore similar work

Aug 27, 2026

CARDINAL Predicts Cardiovascular Risk From Non-contrast Cardiac CT

Cardiovascular risk prediction remains limited by incomplete clinical data and imaging biomarkers that reduce computed tomography (CT) to a small number of handcrafted features. We developed CARDINAL (Cardiovascular Assessment via Representation learning from Deep Imaging with Nested Anatomical Latent embeddings), a clinically grounded framework that learns compact representations from routine non-contrast cardiac CT for major adverse cardiovascular event (MACE) prediction. In 17,659 patients, CARDINAL was evaluated for 1-, 3-, 5-, and 10-year MACE prediction against American Heart Association (AHA) pooled cohort equations (PCE), AHA predicting risk of cardiovascular disease events (PREVENT), coronary artery calcium (CAC), segmentation-derived CT biomarkers, and 70-feature structural radiomics. Gains were largest at longer horizons. At 10 years, CARDINAL (joint) achieved an area under the receiver operating characteristic curve (AUROC) of 0.866 ±\pm 0.020 and an area under the precision-recall curve (AUPRC) of 0.890 ±\pm 0.015, compared with an AUROC of 0.826 ±\pm 0.023 and an AUPRC of 0.826 ±\pm 0.022 for structural radiomics, the strongest baseline. CARDINAL also achieved the highest survival concordance index (C-index), 0.753 ±\pm 0.015, and high-versus-low risk-tertile hazard ratio, 10.78 ±\pm 3.16, with favorable reclassification and exploratory calibration. These findings suggest that non-contrast cardiac CT contains prognostic information beyond conventional risk equations, CAC scoring, and engineered imaging biomarkers.
Sep 30, 2026

From Image Interpretation to Clinical Reasoning: Upstream Physician-Context-Aware Multimodal Learning with Causal Reinforcement Learning

Major adverse cardiovascular events (MACE) remain the leading cause of mortality worldwide. Opportunistic screening using routinely acquired clinical data offers a scalable approach for identifying high-risk individuals before acute events occur. Although chest X-rays (CXRs) capture latent cardiovascular biomarkers and clinical histories provide complementary patient context, existing medical vision-language models are primarily optimized for radiology interpretation rather than prognostic reasoning. We propose a causal reinforcement learning framework for multimodal clinical reasoning that integrates CXRs and physician-authored clinical histories for opportunistic MACE prediction. The framework introduces (1) a role-decoupled dual-LLM architecture that separates reasoning from risk prediction, (2) a dual-action causal reinforcement learning policy for evidence selection and reasoning optimization, and (3) causal token pruning to learn compact multimodal representations. Evaluated on an internal cohort, an emergency department cohort, and the external MIMIC dataset, the proposed framework consistently outperformed unimodal baselines and state-of-the-art medical vision-language models, achieving AUROCs of 0.720, 0.760, and 0.845, respectively. It also substantially improved reasoning quality, achieving higher GREEN scores and higher expert preference while maintaining robust predictive performance across diverse patient populations.
Sep 28, 2026

Disentangling Lung-Cancer CT/LDCT AI: A Systematic Evidence Map of Clinical Tasks, Evidence Chains, and Translational Gaps

Artificial-intelligence studies using computed tomography (CT) for lung cancer are often broadly labelled "prediction" despite addressing clinically distinct tasks. We systematically mapped CT/low-dose CT (LDCT)-centered lung-cancer AI using five-database retrieval, full-text eligibility assessment, role-aware modality/omics extraction, clinical-task classification, and a Multi-Tier Evidence Graph (MTEG). The final corpus comprised 293 studies (2016-2026): 230 Detection, 8 future Risk-prediction, and 55 Other studies. Clinical variables (96.2%), 3D CT/LDCT (73.0%), and radiomics (63.5%) predominated, whereas external validation (29.0%), calibration (20.5%), decision-curve analysis (13.0%), longitudinal CT (17.7%), and saliency/attribution XAI (21.5%) were less frequent. The MTEG comprised 377 nodes and 3,444 edges; only 31 studies (10.6%) completed the six-tier substantive evidence chain, with greatest attrition at reasoning/explanation. Overall, the literature is detection-dominated, genuine future risk prediction remains uncommon, and complete translational evidence chains are rare.